References
- NKF-DOQI. Guideline 4—target hematocrit/hemoglobin for epoetin therapy. In Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure; http://www.kidney.org/professionals/doqi/doqi/ang4.html. (Accessed February 10, 2004.).
- Bommer, J. Saving erythropoietin by administering l-carnitine? Nephrol. Dial. Transplant. 1999, 14 (12), 2819–2821. [PUBMED], [INFOTRIEVE], [CSA]
- Horl, W H. Is there a role for adjuvant therapy in patients being treated with epoetin? Nephrol. Dial. Transplant. 1999, 14 (Suppl. 2), 50–60. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rodríguez-Benítez, P. l-Carnitine in dialysis, more than a commercial affair. Nephrol. Dial. Transplant. 2000, 15, 1477–1478. [CSA], [CROSSREF]
- Hoppel, C.; Ferrari, R.; Dimorro, S.; Sherwood, G. The Physiological Role of l-Carnitine. l-Carnitine and It's Role in Medicine from Function to Therapy; Academic Press Ltd.: London, 1992; 5–21.
- Evangeliou, A.; Vlassopoulos, D A. Carnitine metabolism and deficit—when is supplementation necessary? Curr. Pharm. Biotechnol. 2003, 4 (3), 211–219. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Guarnieri, G.; Situlin, R.; Biolo, G. Carnitine metabolism in uremia. Am. J. Kidney Dis. 2001, 38 (4 Suppl. 1), S63–S67. [PUBMED], [INFOTRIEVE]
- Bartel, L L.; Hussey, J L.; Shrago, E. Effect of dialysis on serum carnitine, free fat acids, and triglyceride levels in man and rat. Metabolism 1982, 31 (9), 944–947. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bellinghieri, G.; Santoro, D.; Calvani, M.; Mallamace, A.; Savica, V. Carnitine and hemodialysis. Am. J. Kidney Dis. 2003, 41 (3 Suppl. 1), S116–S122. [PUBMED], [INFOTRIEVE]
- Debska-Slizien, A.; Owczarzak, A.; Kunicka, D.; Lysiak-Szydlowska, W.; Rutkowski, B. Plasma carnitine profile during chronic renal anemia treatment with recombinant human erythropoietin. Int. J. Artif. Organs 2003, 26 (1), 33–38. [PUBMED], [INFOTRIEVE], [CSA]
- de los Reyes, B.; Navarro, J A.; Perez-Garcia, R.; Liras, A.; Campos, Y.; Bornstein, B.; Arenas, J. Effects of l-carnitine on erythrocyte acyl-CoA, free CoA, and glycerophos pholipid acyltransferase in uremia. Am. J. Clin. Nutr. 1998, 67 (3), 386–390. [PUBMED], [INFOTRIEVE], [CSA]
- Nikolaos, S. Effect of l-carnitine supplementation on red blood cells deformability in hemodialysis patients. Ren. Fail. 2000, 22 (1), 73–80. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Labonia, W D.; Morelli, J R.; Gimenez, M I.; Freuler, P V.; Morelli, O H. Effect of l-carnitine on sodium transport in erythrocytes from dialyzed uremic patients. Kidney Int. 1987, 32 (5), 754–759. [PUBMED], [INFOTRIEVE]
- Arduini, A.; Rossi, M.; Mancinelli, G.; Belfiglio, M.; Scurti, R.; Radatti, G.; Shohet, S B. Effect of l-carnitine and acetyl-l-carnitine on the human erythrocyte membrane stability and deformability. Life Sci. 1990, 47 (26), 2395–2400. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Matsumura, M.; Hatakeyama, S.; Koni, I.; Mabuchi, H.; Muramoto, H. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients. Nephron 1996, 72 (4), 574–578. [PUBMED], [INFOTRIEVE], [CSA]
- Rodriguez-Segade, S.; Alonso De la Pena, C.; Paz, M.; Novoa, D.; Romero, R.; Arcocha, V.; Del Rio, R. Carnitine concentrations in dialyzed and undialyzed patients with chronic renal insufficiency. Ann. Clin. Biochem. 1986, 23 (Pt 6), 671–675. [PUBMED], [INFOTRIEVE]
- Vlassopoulos, D A.; Hadjiyannakos, D K.; Anogiatis, A G.; Evageliou, A E.; Santikou, A V.; Noussias, C V.; Papandreou, P T.; Hadjiconstantinou, V E. Carnitine action on red blood cell osmotic resistance in hemodialysis patients. J. Nephrol. 2002, 15 (1), 68–73. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Arduini, A. Carnitine and its acyl esters as secondary antioxidants. Am. Heart J. 1992, 123, 1726–1727. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mingardi, G.; Bizzi, A.; Cini, M.; Licini, R.; Mecca, G.; Garatini, S. Carnitine balance in hemodialyzed patients. Clin. Nephrol. 1980, 13, 269–270. [PUBMED], [INFOTRIEVE]
- Lindberg, J.; Sadler, R.; Slowik, M. Clinical management of dialysis-related carnitine deficiency: three case studies. Nephrol. News Issues 2003, 17 (5), 73–78. [PUBMED], [INFOTRIEVE], [CSA]
- Donatelli, A.; Terrizzi, C.; Zummo, G.; Russo, V.; Bucalo, M L.; Scarpinato, A. Effects of l-carnitine on chronic anemia and erythrocyte adenosine triphosphate concentration in hemodialysis patients. Curr. Ther. Res. 1987, 41, 620–624.
- Wanner, C.; Horl, W H. Carnitine abnormalities in patients with renal insufficiency: pathophysiological and therapeutic aspects. Nephron 1988, 50 (2), 89–102. [PUBMED], [INFOTRIEVE]
- Kletzmayr, J.; Mayer, G.; Legenstein, E.; Heinz-Peer, G.; Leitha, T.; Horl, W H.; Kovarik, J. Anemia and carnitine supplementation in hemodialyzed patients. Kidney Int. 1999, 69, S93–S106. [CSA], [CROSSREF]
- Leschke, M.; Rumpf, K W.; Eisenhauer, T.; Fuchs, C.; Becker, K.; Kothe, U.; Scheler, F. Quantitative assessment of carnitine loss during hemodialysis and hemofiltration. Kidney Int. 1983, 24, S143–S146.
- Hurot, J M. Effects of l-carnitine supplementation in maintenance hemodialysis patients: a systematic review. J. Am. Soc. Nephrol. 2002, 13 (3), 708–714. [PUBMED], [INFOTRIEVE], [CSA]
- Vesela, E.; Racek, J.; Trefil, L.; Jankovy'ch, V.; Pojer, M. Effect of l-carnitine supplementation in hemodialysis patients. Nephron 2001, 88 (3), 218–223. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Labonia, W D. l-Carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. Am. J. Kidney Dis. 1995, 26 (5), 757–764. [PUBMED], [INFOTRIEVE], [CSA]
- Matsumoto, Y.; Amano, I.; Hirose, S.; Tsuruta, Y.; Hara, S.; Murata, M.; Imai, T. Effects of l-carnitine supplementation on renal anemia in poor responders to erythropoietin. Blood Purif. 2001, 19 (1), 24–32. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Takeda, F.; Teikyo, H.; Morio, A.; Kuwata, S.; Matsusaki, K.; Sano, M. One case report in which oral l-carnitine supplementation showed efficacy in renal anemia in maintenance hemodialysis patient in EPO dose, The 43rd Annual Congress of Japanese Society for Dialysis Therapy, YokohamaJapan, May, 1998.
- Albertazzi, A.; Capelli, P.; Di Paolo, B.; Pola, P.; Tondi, P.; Vaccario, O. Endocrine metabolic effects of l-carnitine in patients on regular dialysis treatment. Proc. Eur. Dial. Transplant Assoc. 1983, 19, 302–307. [PUBMED], [INFOTRIEVE]
- Trovato, G M.; Ginardi, V.; Di Marco, V.; Dell'Aira, A.; Corsi, M. Long-term l-carnitine treatment of chronic anemia of patients with end-stage renal failure. Curr. Ther. Res. 1982, 31, 1042–1049.
- Kooistra, M P.; Struyvenberg, A.; Van Es, A. The response of recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels. Nephron 1991, 57 (1), 127–128. [PUBMED], [INFOTRIEVE]
- Boran, M.; Dalva, I.; Gonenc, F.; Cetin, S. Response to recombinant human erythropoietin (r-Hu EPO) and l-carnitine combination in patients with anemia of end-stage renal disease. Nephron 1996, 73 (2), 314–315. [PUBMED], [INFOTRIEVE], [CSA]
- Patrikarea, A.; Stamelou, K.; Ntaontaki, I.; Patadakis, I T. The effect of combined l-carnitine and erythropoietin administration on the anemia and on the lipid profile of patients on hemodialysis. EDTA Annual Congress, Amsterdam, June 18–21, 1996; Abstracts. Nephrol. Dial. Transplant. 1996, 11, A262.
- Karvadias, D.; Fortounas, C.; Tsouchnikas, J.; Vlachononasios, T.; Barboutis, K. Reduction of the cost of erythropoietin therapy by coadministration of l-carnitine in hemodialysis patients, EDTA 32nd Congress, AthensGreece, 1995.
- National Kidney Foundation. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am. J. Kidney Dis. 2000, 35 (6 Suppl. 2), S1–S140. [CSA]
- Consensus group statement. Role of l-carnitine in treating renal dialysis patients. Dial. Transplant. 1994, 23, 177–181.